Anti-Hypertensive Drugs Flashcards
Etiology of Hypertension
> 90% of patients have essential hypertension
Risk Factors: Family history, obesity, diet, age, physical inactivity, smoking, African Americans (4x more likely), middle age men > females
Hypertension guidelines
sustained systolic BP > 130 mmHg
or
sustained diastolic BP > 80 mmHg
** results from: increased peripheral vascular smooth muscle tone –> increased arteriolar resistance and reduced capacitance on the venous system
Hypertension Categories (4)
Normal: < 120 and < 80 Elevated 120-129 and < 80 Stage 1: 130-139 or 80-89 Stage 2: > 140 or > 90 ** current guideline goals is to reduce BP to < 130/80 mmHg
BP control
Arterial BP: directly proportional to CO and PVR
CO and PVR: controlled by baroreflexes (SNS and RAAS)
** Antihypertensive drugs reduce either or both
Anatomical Sites of BP control (4)
1) Resistance of arterioles
2) Capacitance of Venules
3 Pump output of the Heart
4) Volume (kidneys)
Compensatory Response to Decrease BP
Decreased blood pressure will compensate via two reflex mechanism:
1) Increased sympathetic outflow = tachycardia
2) Increased Renin release = Salt and water retention (increase plasma volume)
Both will lead to Increase BP
** not all hypertensive drugs result in a reflex.. generally drugs that work on the vessels cause reflexes
Stage 1 vs Stage 2 control of Hypertension
how many drugs prescribed
Stage 1: Often controlled with a single drug
Stage 2: Often requires multiple drugs
** life-style changes are the first recommendation to all patients with pre-hypertension and Stage 1 hypertension
Current Recommendations for Treatment
Initiation of pharmacotherapy
- most patients can be started on a single drug (should consider giving 2 drugs of different classes to patients with Stage 2 hypertension)
Stage 2 Hypertension:
- 2 first line drugs of different classes (patients with stage 2 hypertension and average BP of 20/10 mmHg above the BP target)
If BP is still not controlled: vasodilator given
First-Line agents, Second-Line agents, and Other agents
First Line: ACE inhibitors, ARBs, Calcium Channel blockers, and Thiazide diuretics
Second Line: Beta-blockers, aldosterone antagonist
Other: Loop diuretics, alpha-blockers, direct vasodilators, central alpha 2-agonist, renin inhibitors
ACE Inhibitor Drugs
Captopril
Enalapril
Lisinopril
ACE Inhibitor MOA
First Line agent (particularly for diabetics and patients with CKD)
- Decrease BP by decreasing PVR
- inhibits ACE - converts angiotensin I –> Angiotensin II (vasoconstrictor)
- *** blockage of ACE leads to Increased Renin and Angiotensin I due to lack of feedback inhibition
- Decreases Na+ and H2O retention
- Increases bradykinin levels (ACE metabolizes bradykinin) - which leads to decrease BP and mild vasodilation
- DO NOT reflexively increase CO or HR
ACE Inhibitors- Clinical Applications
Hypertension (most effective in white or young patients or can be given with a diuretic to = same effectiveness in black patients
Preserves renal function in patients with nephropathy (diabetic or non-diabetic) – angiotensin II constricts renal efferent arterioles - thus blocking allows arterioles to dilate and decrease GFR (dec. hyper-filtration) ** UNILATERAL
Effective for treating Chronic HF
Standard of care for patients following MI (started 24 hrs after end of infarction)
ACE inhibitors AE
Dry hacking cough (due to increase Bradykinin)
Hyperkalemia - effects due to blocking of aldosterone
Hypotension
Angioedema (rare but life-threatening) < 1%
Acute Renal Failure (patients with bilateral renal artery stenosis) - in bilateral vasoconstriction the efferent arteriole is maintaining GFR and ACE inhibitor will cause a plummet in GFR = Death
Rash, fever, altered taste
ACE Inhibitors Contraindications
Pregnancy
- 1st trimester - Inc. risk of malformations
- 2nd and 3rd trimester - risk of fetal hypotension, anuria, and renal failure
Patients with bilateral renal stenosis
Patients with a history of angioedema related to previous ACEI treatments or hereditary idiopathic angioedema
ARB Drugs
Losartan
Valsartan
ARB MOA
Angiotensin II receptor Blocker (blocks AT1 Receptor)
*** Increased levels of angiotensin II, angiotensin I, renin do to lack of feedback mechanism
First line agent
Alternatives to ACEI (does not produce dry cough)
Dec. in BP causing arteriolar and venous dilation
blocks aldosterone secretion: Dec Na+ and H2O retention
Dec. Diabetic Nephrotoxicity
Does Not Increase Bradykinin Levels
ARB AE
Similar to those of ACE inhibitors
Dry cough does not occur
Angioedema risk is significantly lower than with ACEI
** Losartan reduces plasma uric acid levels by inhibiting URAT1 transporter- useful in patients that also have gout
ARB Contraindications
Pregnancy
Patients with bilateral renal stenosis
Renin Inhibitor
MOA
End Result
Aliskiren
Alternative agent in the treatment of hypertension
** Not clinically as effective than ARB or ACEI
MOA: Inhibits the enzyme activity of Renin and prevents the conversion of angioteninogen to angiotensin I
End Result: Inhibits theA production of angiotensin II and aldosterone
Renin Inhibitor AE
Similar to those of an ACEI
No dry cough
Decreased risk of angioedema than with ACEI
Calcium channel blockers
Verapamil (non-dihydropyridines)
Diltiazem (non-dihydropyridines)
Nifedipine (dihydropyridine)
Amlodipine (dihydropyridine)
First line agent (particularly black and/or the elderly)
Separated into two classes: (non-dihydropyridines or dihydropyridines)
Verapamil and Diltiazem
Verapamil:
Least selective Ca2+ channel blocker
significant effects in cardiac and vascular smooth muscle - relaxation and decrease contractility and HR
Uses:
- treat angina, supra ventricular tachyarrhythmias, hypertension, migraine, and cerebral vasospasm
Diltiazem:
Effects cardiac and vascular smooth muscle (less effective on cardiac then verapamil)
Good side-effect profile
Uses:
- treat angina, hypertension, supra ventricular tachyarrhythmias, and cerebral vasospasm
Dihydropyridines
Nifedipine
Amlodipine
Greater affinity for vascular Ca2+ channels than for cardiac channels
Reduces calcium entry into the smooth muscle to causes coronary and peripheral vasodilation and lower BP
Primary use is to treat hypertension, can also be used for angina
** Not used for cardiac arrhythmias
Calcium channel blockers - Clinical App.
Hypertension (Black of elderly patients)
Have intrinsic natriuretic effects (diuretic not needed)
Useful in patients with asthma, diabetes, peripheral vascular disease
Calcium channel blockers- PK
High-doses of short-acting dihydropyridine blockers can increase risk of MI (due to reflex stimulation)
Sustained release preparations are preferred
Calcium channel blockers- AE
Verapamil
- Constipation, negative inotropic signals, gingival hyperplasia
Dihydropyridines
- hypotension, peripheral edema (feet/ankles), dizziness, headache, fatigue, gingival hyperplasia, flushing, REFLEX TACHYCARDIA (short-acting preparations)
Calcium channel blockers Contraindications
Non-dyhyrdopyridines
- contraindicated in patients taking b-blockers or who have a 2nd or 3rd degree AV block, or severe left ventricular systolic dysfunction
Diuretic Drugs and MOA
Thiazide (Hydrochlorothiazide, Metolazone, Chlorthalidone)
First line agent (particularly black and/or elderly patients)
MOA
- Lower BP by increasing Na+ and H2O excretion- decreasing blood volume
- Long term treatment = normal plasma volume but sustained decrease in PVR